Qedas, UAB

Company age: 2 y. 1 mo.

Update

Company overview

Company name Qedas, UAB
Company code 306966326
VAT code LT100017180717
Registered address Biržų r. sav., Širvėnos sen., Rinkuškių k., Jono Variakojo g. 19, LT-41188
Registration date 2024-08-08 Company age: 2 y. 1 mo.
Phone Phone
Email Email
Company manager For registered members only Log in
Revenue (2025) 83,730 € History
Profit (2025) -89,566 € History
Share capital 51,000 €
Number of employees 1 History
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity Retail sale of pharmaceutical products
Ownership form Private without foreign capital

Download a detailed company report

Make confident decisions with all the information about Qedas, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Qedas, UAB (company code 306966326) is an operational private limited liability company registered in 2024. It is a privately owned entity, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital, and its governance is listed as CEO only. The company is classified among national private non-financial companies and is a micro-sized business. Its main activity under EVRK G.47.73.00 is retail sale of pharmaceutical products. The registered address is Jono Variakojo g. 19, Rinkuškiu k., Širvenos sen., Biržu r. sav., Panevežio apskr. Financially, revenue increased to €83.7K in 2025 from €558 in 2024, while the company remained loss-making with a net loss of €89.6K in 2025; the net profit margin was -107.0%. At the end of 2025, equity was negative at -€40.2K, liabilities amounted to €98.7K, and total assets were €50.0K. The company employed an average of 1 person in 2024, 2025, and so far in 2026.